Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Wingstop Reports Second Quarter 2026 Financial Results and Declares Quarterly Dividend

Wingstop Inc. disclosed its financial results for the fiscal second quarter ended June 27, 2026, in a press release issued on July 29, 2026. The company reported results using both standard accounting measures and supplemental non-GAAP financial metrics including EBITDA and Adjusted EBITDA. The …

Vinay Lochav | 29 July 2026

Peabody Energy Declares Quarterly Dividend and Reports Second Quarter 2026 Financial Results

Peabody Energy Corporation announced its second quarter 2026 financial results on July 29, 2026, alongside a declaration of a quarterly dividend. The company's Board of Directors approved a dividend of $0.075 per share, payable to shareholders on September 3, 2026. The disclosure included selected …

Anjali Anand | 29 July 2026

Entergy Corporation Reports Second Quarter 2026 Results and Financial Condition

Entergy Corporation disclosed its operational performance and financial condition for the second quarter of 2026 on July 29, 2026. The disclosure, submitted across multiple subsidiary entities including Entergy Arkansas, Entergy Louisiana, Entergy Mississippi, Entergy New Orleans, Entergy Texas, and System Energy Resources, provides investors …

Aditi Sarkar | 29 July 2026

General Dynamics Reports Second Quarter 2026 Financial Results

General Dynamics Corporation disclosed its financial performance for the quarter ended July 5, 2026, in an announcement released on July 29, 2026. The defense and aerospace contractor, headquartered in Reston, Virginia, provided investors with an update on operational and financial metrics for the second …

Shwetambri Chauhan | 29 July 2026

Wolfspeed Appoints Andreas Mattes as Director and Compensation Committee Chair

Wolfspeed, Inc. has appointed Andreas W. Mattes to its Board of Directors effective immediately, with concurrent assignment as chair of the Compensation Committee. Mattes brings extensive leadership experience from roles including president and chief executive officer of Coherent, Inc., and currently serves on multiple …

Nitish Kishor | 29 July 2026

LB Pharmaceuticals Raises $150 Million in Private Placement to Fund LB-102 Pipeline Expansion

LB Pharmaceuticals Inc (NASDAQ: LBRX) announced on July 28, 2026, that it has entered into a Securities Purchase Agreement to raise approximately $150 million in gross proceeds through a private placement of common stock and pre-funded warrants. The funds will support pipeline expansion of …

Nitish Kishor | 29 July 2026

LB Pharmaceuticals Raises $150 Million in Private Placement to Expand LB-102 Pipeline

LB Pharmaceuticals Inc (NASDAQ: LBRX) announced on July 29, 2026, that it has secured approximately $150 million in gross proceeds through a private placement of common stock and pre-funded warrants. The pharmaceutical company plans to deploy the capital toward pipeline expansion of its lead …

Nitish Kishor | 29 July 2026

Clean Harbors Reports Second Quarter 2026 Financial Results and Operational Performance

Clean Harbors, Inc. disclosed its second quarter 2026 results on July 29, 2026, providing investors with an operational and financial update covering the period ended June 30, 2026. The Massachusetts-based environmental and waste management services company released its earnings announcement through an official press …

Aakashdeep | 29 July 2026

Arthur J. Gallagher Announces Passing of Lead Independent Director David Johnson, Restructures Board Leadership

Arthur J. Gallagher & Co. disclosed on July 22, 2026, that David Johnson, the company's Lead Independent Director, has passed away. Following this development, the board reduced its size from nine to eight members on July 23, 2026, and appointed Ralph Nicoletti as the …

Aditi Sarkar | 29 July 2026

Standard BioTools Files Amended Disclosure on Mass Cytometry Business Sale to Multiplex Bio

Standard BioTools Inc. has filed an amended current report disclosing details of its agreement to sell its mass cytometry business to Multiplex Bio Inc. The filing, submitted on July 29, 2026, includes the complete Share and Asset Purchase Agreement as an exhibit and reiterates …

Vinay Lochav | 29 July 2026
Support

Hi! How can we help you today?

Loading…